Generic Health Claims

Scientific experts on European Food Safety Authority’s Panel on Dietetic Products, Nutrition and Allergies (NDA) have adopted opinions on 808 generic health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. With this third series of opinions, European Food Safety Authority (EFSA) has finished assessing 1,745 claims from a list of almost 4,700 health claims compiled by Member States and the EU Commission. These opinions have been sent to the European Commission and to Member States which are responsible for the authorization of the claims. Among others, several generic health claims applications for branched-chain amino acids (BCAA) affecting some aspects of exercise (i.e., mental state, growth of muscle, recovery) were evaluated by EFSA. However, EFSA concluded that cause and effect relationships have not been established between the consumption of BCAA and the claimed effects. EFSA is supposed to finalize the evaluations of all remaining general function health claims (other than botanicals) by the end of June 2011.


REACH Regulation

REACH is the Regulation (EC) No 1907/2006 on Registration, Evaluation, Authorisation and Restriction of Chemicals. It entered into force on 1st June 2007 in order to streamline and improve the former legislative framework on chemicals of the EU. REACH compliance requirements apply to European Union businesses that import, use, or manufacture certain chemical substances in the EU and as such it impacts amino acids used in non-food and non-pharmaceutical applications. REACH stipulates that amino acids not used in food or pharmaceuticals are subjected to REACH requirements. The requirements depend on the tonnage of the substance and enable data-sharing in order to lower regulatory and research costs. For further guidance, see: